By Audrey Erbes, PhD, Life Science Marketing and Business Development consultant
The market moved up on the opening trading day of the year with the Dow Jones Industrial Average jumping 155.91 points, or 1.50%, to close at 10,583.96. The large-cap S&P 500 Index gained 17.89 points, or 1.60%, to end at 1,132.99.
We learned the U.S. FDA approved 26 new molecular entities (NMEs) in 2009 compared with 25 in 2008 and only 17 in 2007 which is a nice change after years of decline.
“The U.S. National Institutes of Health plans to create or save 50,000 jobs with its $10 billion in federal stimulus funds, boosting medical research and returning $2.25 on the dollar in goods and services, the agency’s director Francis Collins said.” See the full article in Bloomberg news titled NIH Stimulus Money Adds Jobs and Research After Lag.
“Bankers and buysiders are adamant that despite a difficult fourth quarter —and in part because of it — they have positive expectations for 2010. Their views are based on factors including the wrapping up of healthcare reform, a full calendar of milestones, beaten down P/Es for big cap biotechs, and the potential ascendance of a new class of bellwethers.” See BioCentury, Jan. 4, 2010, p. 1